Archive: 09/08/2022

Breast cancer: New drug shrinks brain metastases

An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy ...

Aug 9, 2022

0

945

Sexual dysfunction high among women with lung cancer

Sexual dysfunction is highly prevalent in women with lung cancer with most survey participants reporting little to no interest in sexual activity, according to research led by Narjust Florez (Duma), MD, associate director ...

Aug 9, 2022

0

2

Chinese researchers develop lung cancer risk prediction nomogram for female non-smokers

About 53% of lung cancers in females are not attributable to smoking worldwide and a new model presented today at the IASLC World Conference on Lung Cancer may allow clinicians the ability to assess and stratify lung cancer ...

Aug 9, 2022

0

11

Researchers suggest air pollution be included as risk factor for patients with lung cancer and have never smoked

Researchers from Vancouver, British Columbia examine the effect of duration of past exposure to air pollution with lung cancer diagnosis.

Aug 9, 2022

0

2

First-line pembrolizumab or placebo combined with etoposide and platinum for ES-SCLC

Long-term follow up of patients with extensive stage small cell lung cancer who were given pembrolizumab and etoposide/platinum (EP) versus placebo + etoposide/platinum as first-line therapy support the continued exploration ...

Aug 9, 2022

Robotic-assisted lobectomy provides better patient-reported quality of life compared to video-assisted lobectomy

Robot-assisted lung surgery is a cost-effective intervention that yields better patient-reported quality of life measures, compared with video-assisted lung surgery, according to research reported today at the IASLC 2022 ...

Aug 9, 2022

0

3

Association between KRAS/STK11/KEAP1 mutations and outcomes in POSEIDON

Patients with metastatic non-small cell lung cancer who received a combined therapy of tremelimumab, durvalumab and chemotherapy experienced longer overall survival compared with those who received chemotherapy alone, regardless ...

Aug 9, 2022

Informed consent forms for lung cancer clinical trials may be a barrier to informed trial participation

Informed consent forms are overwhelming for patients. They are written at a level that is too high for most patients, thus possibly impeding real informed consents, according to a report given today at the IASLC World Conference ...

Aug 9, 2022

0

8

Major test of first possible Lyme vaccine in 20 years begins

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years—in hopes of better fighting the tick-borne threat.

Aug 9, 2022

0

196

Efforts to save money on prescription drugs associated with increased stroke risk for seniors

Atrial fibrillation (AF) is a major risk factor for stroke, and for decades the anticoagulant warfarin was the standard treatment for lowering that hazard. However, numerous drug and food interactions make warfarin burdensome ...

Aug 9, 2022

0

4

page 8 from 9

«
»